APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer

Recent studies have demonstrated that APOC1 is associated with cancer progression, exerting cancerpromoting and immune infiltration-promoting effects. Nevertheless, there is currently no report on the presence of APOC1 in ovarian cancer (OV).